Psyllid ID: psy5613


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010
MSLGNTLSAASTRHGQEEDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTVDLNV
cccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEEccccccccccccccccccccccccccccccccccccEEEcccccEEEcccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccEEcccEEEcccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEEEcccccccccccccccccccccccccccccccccccccccEEEcccccccccccccEEccccccccccccccccccccEEccccccccccccc
cccccccccccccccEccccccccEccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccEEEEEcccEEEEcccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccEcccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEccccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEEcccEEEEccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccEEEEccccEEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEEcccEEEEccccccccccccccccccccccccccccccccccccccEEEEEEccccccccEEcccccEEEEcccccHHHHHHHHHHHcccHHcccEcccc
mslgntlsaastrhgqeedkFFTYFcvnsvpppvqqdtcncvpnavckdevcvclpdfygdgyvscrpecvlnsdcpsnkacirnkcknpcvpgtcgegaicdvvnhavmctcppgttgspfiqckpiqnepvytnpcqpspcgpnsqcreinhqavcsclpnyfgsppgcrpectvnsdcpldracqnqkcvdpcpgscgyrarcqvynhnpvcscppgytgnpfsqcllpptptptqatptdpcfpspcgsnarcrvqNEHALceclpdyygnpyegcrpeclinsdcplslaciknhcrdpcpgtcgvqaicsvsnhipicycpagftgdafrqcspipqrepeyrdpcsttqcglnaICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVytvqpviqedtcncvpnaecrdgvcvclpdyygdgyvscrpecvqnsdcprnkacirnkcknpcvpgtcgegaicdvinhavmctcppgttgspfiqckpvqnepvytnpcqpspcgpnsqcrevhKQAVcsclpnyfgsppncrpectvnsdcpldkacfnqkcvdpcpgtcgqnancrvinhnpsctckagftgdprvfcsripppppqesppeyvnpcipspcgpysqcrdingspscsclpnyigappncrpecvqntecpydkacinekcrdpcpgscgqgaqcrvinhspvcycpdgfigdafsscypkpiepiqapeqqadpcicapnavcrdnvcvclpdyygdgytvcrpecvrnsdcannkacirnkcknpcvpgtcgegaicdvinhsvvcscppgttgspfiqckpviqepvytnpcqpspcgpnsqcrevnkqavcsclpnyfgsppncrpectvntdcpldkacvnqkcvdpcpgscgqnancrvinhspictcrpgftgeprircspiprklfvpadqasqenlesdvhqyHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTVDLNV
mslgntlsaastrhgqeeDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAyqttselhqtvdlnv
MSLGNTLSAASTRHGQEEDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLpptptptqatptdpCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGaaqcacllllqHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIpppppqesppeYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTVDLNV
*******************KFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPC*********QCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLL*******************CGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIP*****YRDPCSTTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTN************CREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFC******************CIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQ********QCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVP***********DVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTS**********
MSLGNTLSAASTRHGQEEDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTVDLNV
***************QEEDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQ**********TTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTVDLNV
****NTLSAASTRHGQEEDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTV**N*
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MSLGNTLSAASTRHGQEEDKFFTYFCVNSVPPPVQQDTCNCVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYNHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGAAQCACLLLLQHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIPRKLFVPADQASQENLESDVHQYHHLRLLSHHRNQSIHAIHHHAVLTLSVETSTAIHHVLAYQTTSELHQTVDLNV
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query1010 2.2.26 [Sep-21-2011]
P46530 2437 Neurogenic locus notch ho yes N/A 0.663 0.274 0.248 2e-16
Q99466 2003 Neurogenic locus notch ho yes N/A 0.668 0.336 0.231 8e-14
Q9R172 2319 Neurogenic locus notch ho yes N/A 0.555 0.241 0.251 9e-14
Q01705 2531 Neurogenic locus notch ho yes N/A 0.612 0.244 0.246 1e-12
P100791064 Fibropellin-1 OS=Strongyl no N/A 0.617 0.586 0.237 9e-12
P46531 2555 Neurogenic locus notch ho no N/A 0.612 0.242 0.246 1e-11
Q07008 2531 Neurogenic locus notch ho no N/A 0.744 0.297 0.244 4e-11
Q9UM47 2321 Neurogenic locus notch ho no N/A 0.390 0.169 0.254 5e-11
Q61982 2318 Neurogenic locus notch ho no N/A 0.620 0.270 0.236 2e-10
P21783 2524 Neurogenic locus notch pr N/A N/A 0.387 0.154 0.258 9e-10
>sp|P46530|NOTC1_DANRE Neurogenic locus notch homolog protein 1 OS=Danio rerio GN=notch1a PE=2 SV=1 Back     alignment and function desciption
 Score = 89.4 bits (220), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 228/917 (24%), Positives = 335/917 (36%), Gaps = 247/917 (26%)

Query: 96  CGEGAICDVV-NHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCREINH 154
           C  G IC+   +    C CP    G+   QC+       + NPC PSPC     CR    
Sbjct: 29  CQNGGICEYKPSGEASCRCPADFVGA---QCQ-------FPNPCNPSPCRNGGVCR---- 74

Query: 155 QAVCSCLPNYFGSPPGCRPECTVN-SD----CPLDRACQNQKCVDPCPGSCGYRARCQVY 209
                  P   G+  G + +C +  SD     P++ AC N  C +   G+C       + 
Sbjct: 75  -------PQMQGNEVGVKCDCVLGFSDRLCLTPVNHACMNSPCRNG--GTCSL-----LT 120

Query: 210 NHNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNARCRVQNEHALCECL 269
                C C PG++G     C L            DPC  +PC +  +C     H +C C 
Sbjct: 121 LDTFTCRCQPGWSG---KTCQL-----------ADPCASNPCANGGQCSAFESHYICTCP 166

Query: 270 PDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPGTCGVQAICSVSNHIPICYCPAG 329
           P+++G   + CR +    ++C +S          P P   G   I  V ++  +C CP  
Sbjct: 167 PNFHG---QTCRQDV---NECAVS----------PSPCRNGGTCINEVGSY--LCRCPPE 208

Query: 330 FTGDAFRQCSPIPQREPEYRDPCSTTQCGLNAICTVINGAAQ-CACL--LLLQHHIHKNQ 386
           +TG       P  QR      PC  + C     C   +     C+CL     Q   H   
Sbjct: 209 YTG-------PHCQR---LYQPCLPSPCRSGGTCVQTSDTTHTCSCLPGFTGQTCEHNVD 258

Query: 387 DMDQYI---------SLGYMLCHMDILSSEYIQVYTVQPVIQEDTCNCVPNAECRDGV-- 435
           D  Q+           +    CH D     +   Y  + V   D C   PNA C++G   
Sbjct: 259 DCTQHACENGGPCIDGINTYNCHCD---KHWTGQYCTEDV---DECELSPNA-CQNGGTC 311

Query: 436 --------CVCLPDYYGDGYVSCRPECVQNS----------------DCPRNKACIRNKC 471
                   CVC+  + GD       +C   +                +CP  +  +    
Sbjct: 312 HNTIGGFHCVCVNGWTGDDCSENIDDCASAACSHGATCHDRVASFFCECPHGRTGLLCHL 371

Query: 472 KNPCVPGTCGEGAICDV--INHAVMCTCPPGTTGSP------------------------ 505
            + C+   C +G+ CD   ++   +CTCPPG TGS                         
Sbjct: 372 DDACISNPCQKGSNCDTNPVSGKAICTCPPGYTGSACNQDIDECSLGANPCEHGGRCLNT 431

Query: 506 --FIQCKPVQNE-----PVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPE 558
               QCK +Q        +  N C+ +PC  ++ C +      C C+P Y G        
Sbjct: 432 KGSFQCKCLQGYEGPRCEMDVNECKSNPCQNDATCLDQIGGFHCICMPGYEGV------F 485

Query: 559 CTVNSDCPLDKACFNQKCVDP-------CP-GTCGQNANCRV-INHNPSCTCKAGF--TG 607
           C +NSD    + C N KC+D        CP G  G  + C+V ++   S  CK G   T 
Sbjct: 486 CQINSDDCASQPCLNGKCIDKINSFHCECPKGFSG--SLCQVDVDECASTPCKNGAKCTD 543

Query: 608 DPRVFCSRIPPPPPQESPPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRP 667
            P  +     P          +N C  SPC  Y  CRD   S +C C P Y G       
Sbjct: 544 GPNKYTCECTPGFSGIHCELDINECASSPC-HYGVCRDGVASFTCDCRPGYTGRL----- 597

Query: 668 ECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIG----DAFSSC 723
            C  N        C+++ CR+        G  C+   ++ +C CP G  G         C
Sbjct: 598 -CETNI-----NECLSQPCRN--------GGTCQDRENAYICTCPKGTTGVNCEINIDDC 643

Query: 724 YPKP------IEPIQAPEQQADPCICAP---NAVCRDNV--CVCLPDYYG----DG---Y 765
             KP      I+ I   E     C+C P    ++C  N+  C   P + G    DG   +
Sbjct: 644 KRKPCDYGKCIDKINGYE-----CVCEPGYSGSMCNINIDDCALNPCHNGGTCIDGVNSF 698

Query: 766 TVCRPECVRNSDCANNKACIRNKC-KNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPF 824
           T   P+  R++ C +      N+C  NPC+ G+C      D IN S  C C  G  G   
Sbjct: 699 TCLCPDGFRDATCLSQ----HNECSSNPCIHGSC-----LDQIN-SYRCVCEAGWMGR-- 746

Query: 825 IQCKPVIQEPVYTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCP 884
             C       +  N C  +PC     C+++    +C+C   + G      P C +N +  
Sbjct: 747 -NCD------ININECLSNPCVNGGTCKDMTSGYLCTCRAGFSG------PNCQMNINEC 793

Query: 885 LDKACVNQ-KCVDPCPG 900
               C+NQ  C+D   G
Sbjct: 794 ASNPCLNQGSCIDDVAG 810




Implicated in cell fate specifications during embryo development. May be involved in the formation of the neural plate, notochord and brain vesicles.
Danio rerio (taxid: 7955)
>sp|Q99466|NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 Back     alignment and function description
>sp|Q9R172|NOTC3_RAT Neurogenic locus notch homolog protein 3 OS=Rattus norvegicus GN=Notch3 PE=2 SV=2 Back     alignment and function description
>sp|Q01705|NOTC1_MOUSE Neurogenic locus notch homolog protein 1 OS=Mus musculus GN=Notch1 PE=1 SV=3 Back     alignment and function description
>sp|P10079|FBP1_STRPU Fibropellin-1 OS=Strongylocentrotus purpuratus GN=EGF1 PE=1 SV=2 Back     alignment and function description
>sp|P46531|NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens GN=NOTCH1 PE=1 SV=4 Back     alignment and function description
>sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus GN=Notch1 PE=2 SV=2 Back     alignment and function description
>sp|Q9UM47|NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 Back     alignment and function description
>sp|Q61982|NOTC3_MOUSE Neurogenic locus notch homolog protein 3 OS=Mus musculus GN=Notch3 PE=1 SV=1 Back     alignment and function description
>sp|P21783|NOTCH_XENLA Neurogenic locus notch protein homolog OS=Xenopus laevis GN=notch1 PE=1 SV=3 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1010
170059510 6860 dumpy [Culex quinquefasciatus] gi|167878 0.894 0.131 0.540 0.0
270013391 21117 hypothetical protein TcasGA2_TC011986 [T 0.858 0.041 0.553 0.0
442625920 18014 dumpy, isoform W [Drosophila melanogaste 0.862 0.048 0.521 0.0
442625928 19560 dumpy, isoform AA [Drosophila melanogast 0.862 0.044 0.521 0.0
442625918 20404 dumpy, isoform V [Drosophila melanogaste 0.862 0.042 0.521 0.0
442625916 21657 dumpy, isoform U [Drosophila melanogaste 0.862 0.040 0.521 0.0
442625914 22300 dumpy, isoform T [Drosophila melanogaste 0.862 0.039 0.521 0.0
157133857 5429 hypothetical protein AaeL_AAEL012905 [Ae 0.868 0.161 0.528 0.0
442625908 22949 dumpy, isoform Q [Drosophila melanogaste 0.862 0.037 0.521 0.0
442625910 22830 dumpy, isoform R [Drosophila melanogaste 0.862 0.038 0.521 0.0
>gi|170059510|ref|XP_001865394.1| dumpy [Culex quinquefasciatus] gi|167878260|gb|EDS41643.1| dumpy [Culex quinquefasciatus] Back     alignment and taxonomy information
 Score =  930 bits (2403), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 533/987 (54%), Positives = 657/987 (66%), Gaps = 84/987 (8%)

Query: 34   VQQDTCN---CVPNAVCKDEVCVCLPDFYGDGYVSCRPECVLNSDCPSNKACIRNKCKNP 90
            V+ D CN   C PNA C + +C CLP++ GD Y  CRPECVLNSDCP +KACIR+KC +P
Sbjct: 2595 VRDDPCNPSPCGPNAQCNNGICSCLPEYQGDPYQGCRPECVLNSDCPRDKACIRSKCIDP 2654

Query: 91   CVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPNSQCR 150
            C PGTCG+ AIC+V+NH  MC+CP G  G+ F+QC+P Q  PV TNPC PSPCGPNSQCR
Sbjct: 2655 C-PGTCGQDAICEVINHIPMCSCPNGMAGNAFVQCRPQQAPPV-TNPCNPSPCGPNSQCR 2712

Query: 151  EINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVYN 210
            EIN QAVCSC+P + GSPP CRPEC V+S+CP ++AC NQKC DPCPG+CG  ARC V N
Sbjct: 2713 EINGQAVCSCVPGFIGSPPTCRPECVVSSECPQNQACNNQKCRDPCPGTCGVGARCSVVN 2772

Query: 211  HNPVCSCPPGYTGNPFSQCLLPPTPTPTQATPTDPCFPSPCGSNA--------------- 255
            HNP+CSCP  +TG+PF +C  P   TP Q TP +PC P+PCG NA               
Sbjct: 2773 HNPICSCPERFTGDPFVRCQ-PIIETPVQMTPVNPCQPNPCGPNAECRPVAEPVYKNPCQ 2831

Query: 256  --------RCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIKNHCRDPCPG 307
                    +CR  N  A+C CLP Y G+P  GCRPEC+ +S+CPL  AC+   C DPCPG
Sbjct: 2832 PNPCGPNSQCREINGQAVCSCLPTYIGSP-PGCRPECVTSSECPLDRACVNQKCVDPCPG 2890

Query: 308  TCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIP----QREPEYRDPCSTTQCGLNAIC 363
            TCG  A C+V+NH PIC C +G+TGD F +C P P      +   RDPC  + CG N+ C
Sbjct: 2891 TCGTNARCNVNNHSPICSCQSGYTGDPFTRCYPNPPPPQDTQVVVRDPCVPSPCGPNSQC 2950

Query: 364  TVINGAAQCACLL-------------LLQHHIHKNQD-MDQYI--------SLGY---ML 398
              ING   C+CL+              +      NQ  M++           +G    ++
Sbjct: 2951 RNINGVPSCSCLVNYIGSPPNCRPECTINAECPSNQACMNEKCRDPCPGSCGIGARCNVI 3010

Query: 399  CHMDILSSE-----------YIQVYTVQPVIQEDTCN---CVPNAECRDGVCVCLPDYYG 444
             H  I + E           Y +    +  +++D CN   C PNA+C +G+C CLP+Y G
Sbjct: 3011 NHTPICTCESGYTGDPFTNCYPEPPPPREPVRDDPCNPSPCGPNAQCNNGICTCLPEYQG 3070

Query: 445  DGYVSCRPECVQNSDCPRNKACIRNKCKNPCVPGTCGEGAICDVINHAVMCTCPPGTTGS 504
            D Y  CRPECV NSDCPR+KACIR+KC +PC PGTCG+ AIC+VINH  MC+CP G  G+
Sbjct: 3071 DPYQGCRPECVLNSDCPRDKACIRSKCIDPC-PGTCGQDAICEVINHIPMCSCPNGMAGN 3129

Query: 505  PFIQCKPVQNEPVYTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSD 564
             F+QC+P Q  PV TNPC PSPCGPNSQCRE++ QAVCSC+P + GSPP CRPEC V+S+
Sbjct: 3130 AFVQCRPQQAPPV-TNPCNPSPCGPNSQCREINGQAVCSCVPGFIGSPPTCRPECVVSSE 3188

Query: 565  CPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGDPRVFCSRIPPPPPQES 624
            CP ++AC NQKC DPCPGTCG  A C V+NHNP C+C   FTGDP V C  I   P Q +
Sbjct: 3189 CPQNQACNNQKCRDPCPGTCGVGARCSVVNHNPICSCPERFTGDPFVRCQPIIETPVQMT 3248

Query: 625  PPEYVNPCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINE 684
            P   VNPC P+PCGP ++CR +  SPSC+CL N IG+PPNCRPEC+ N+EC  + ACI +
Sbjct: 3249 P---VNPCQPNPCGPNAECRPVGDSPSCTCLDNMIGSPPNCRPECISNSECASNLACIRQ 3305

Query: 685  KCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICA 744
            KC+DPC G+CG  A+CRV++H+P+C C  GF GD F+ C P   +  + P     P  C 
Sbjct: 3306 KCQDPCTGACGANAECRVVSHTPMCICSIGFTGDPFTQCLPVQQDVPREPSSPCTPSPCG 3365

Query: 745  PNAVCRD----NVCVCLPDYYGDGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGE 800
             NA CR+      C C+ D++G+ Y  CRPECV NSDC +N+AC+RNKC++PC PGTCG+
Sbjct: 3366 ANANCREQNGAGSCTCIEDHFGNPYEGCRPECVLNSDCPSNRACVRNKCQDPC-PGTCGQ 3424

Query: 801  GAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEP-VYTNPCQPSPCGPNSQCREVNKQAV 859
             A C V+NH   C+C PG  G PF  C    +EP  Y NPCQP+PCGPNSQCREVN Q V
Sbjct: 3425 NANCQVVNHLPSCTCIPGYEGDPFRFCNIQQREPPAYQNPCQPNPCGPNSQCREVNGQGV 3484

Query: 860  CSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTC 919
            CSCLP Y GSPP CRPEC  +++C LDKACVNQKCVDPCPG+CG NA C V NHSPIC+C
Sbjct: 3485 CSCLPTYIGSPPGCRPECVTSSECSLDKACVNQKCVDPCPGTCGANARCNVNNHSPICSC 3544

Query: 920  RPGFTGEPRIRCSPIPRKLFVPADQAS 946
            + G+TG+P  RC P PRK F   D  S
Sbjct: 3545 QSGYTGDPFTRCYPNPRKTFKFIDDES 3571




Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270013391|gb|EFA09839.1| hypothetical protein TcasGA2_TC011986 [Tribolium castaneum] Back     alignment and taxonomy information
>gi|442625920|ref|NP_001260038.1| dumpy, isoform W [Drosophila melanogaster] gi|440213323|gb|AGB92574.1| dumpy, isoform W [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|442625928|ref|NP_001260042.1| dumpy, isoform AA [Drosophila melanogaster] gi|440213327|gb|AGB92578.1| dumpy, isoform AA [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|442625918|ref|NP_001260037.1| dumpy, isoform V [Drosophila melanogaster] gi|440213322|gb|AGB92573.1| dumpy, isoform V [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|442625916|ref|NP_001260036.1| dumpy, isoform U [Drosophila melanogaster] gi|440213321|gb|AGB92572.1| dumpy, isoform U [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|442625914|ref|NP_001260035.1| dumpy, isoform T [Drosophila melanogaster] gi|440213320|gb|AGB92571.1| dumpy, isoform T [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|157133857|ref|XP_001663043.1| hypothetical protein AaeL_AAEL012905 [Aedes aegypti] gi|108870667|gb|EAT34892.1| AAEL012905-PA [Aedes aegypti] Back     alignment and taxonomy information
>gi|442625908|ref|NP_001260032.1| dumpy, isoform Q [Drosophila melanogaster] gi|440213317|gb|AGB92568.1| dumpy, isoform Q [Drosophila melanogaster] Back     alignment and taxonomy information
>gi|442625910|ref|NP_001260033.1| dumpy, isoform R [Drosophila melanogaster] gi|440213318|gb|AGB92569.1| dumpy, isoform R [Drosophila melanogaster] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1010
FB|FBgn005319622 dp "dumpy" [Drosophila melanog 0.858 39.40 0.437 6.3e-215
MGI|MGI:99460 2318 Notch3 "notch 3" [Mus musculus 0.811 0.353 0.257 5.2e-36
ZFIN|ZDB-GENE-041001-184 8328 si:dkey-30j22.1 "si:dkey-30j22 0.784 0.095 0.245 5.3e-36
ZFIN|ZDB-GENE-000329-5 2468 notch3 "notch homolog 3" [Dani 0.8 0.327 0.263 7.3e-36
RGD|620761 2319 Notch3 "notch 3" [Rattus norve 0.811 0.353 0.261 1.8e-35
UNIPROTKB|Q9R172 2319 Notch3 "Neurogenic locus notch 0.811 0.353 0.261 1.8e-35
UNIPROTKB|I3L9D5 1175 NOTCH3 "Uncharacterized protei 0.799 0.686 0.256 4.6e-35
UNIPROTKB|E1BGE01572 E1BGE0 "Uncharacterized protei 0.456 0.293 0.273 6.8e-35
UNIPROTKB|Q04721 2471 NOTCH2 "Neurogenic locus notch 0.774 0.316 0.253 2.3e-34
UNIPROTKB|F1NXF91371 Gga.18391 "Uncharacterized pro 0.444 0.327 0.265 2.5e-34
FB|FBgn0053196 dp "dumpy" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 2103 (745.4 bits), Expect = 6.3e-215, P = 6.3e-215
 Identities = 416/951 (43%), Positives = 540/951 (56%)

Query:    32 PPVQQDTC----NCVPNAVCKDEVCV--CLPDFYGDGYVSCR-----PECVLNSDCPSN- 79
             PP  +  C     C  N  C ++ CV  C P   G   + CR       C+ +     + 
Sbjct: 13992 PPNCRPECISNSECPTNQACINQKCVDPC-PGLCGQNAI-CRVFSHSAMCLCDGGFTGDP 14049

Query:    80 -KAC--IRN---KCKNPCVPGTCGEGAICDVVNHAVMCTCPPGTTGSPFIQCKPIQNEPV 133
                C  IR+   +   PC P  CG  A C+    A  C C P   G+P+  C+P   E V
Sbjct: 14050 FSQCSPIRDSPPEVLQPCNPSPCGVNAKCEERGGAGSCQCLPDYFGNPYDGCRP---ECV 14106

Query:   134 YTNPCQPSPCGPNSQCRE-----INHQAVCSCLPNYFGSPPGCRPECTVN--SDCPLD-R 185
               + C  +    N +CR+         A C  + N+  +   C    T +  S C +   
Sbjct: 14107 LNSDCPSNQACVNQKCRDPCPGTCGQNAECQVV-NHLATC-NCLVGYTGDPYSICRITVN 14164

Query:   186 ACQNQKCVDPC-PGSCGYRARCQVYNHNPVCSCPPGYTGNPFS---QCLLXXXXXXXXXX 241
                 +  V+PC P  CG  ++C+  N   VCSC P + G+P +   +C            
Sbjct: 14165 EPPERVYVNPCQPSPCGPNSQCREVNEQGVCSCLPEFIGSPPACRPECTSSSECAADKAC 14224

Query:   242 XXXXCF---PSPCGSNARCRVQNEHALCECLPDYYGNPYEGCRPECLINSDCPLSLACIK 298
                 C    P+ CG  A CRV+N + +C CL  + G+P+  C  +       P     ++
Sbjct: 14225 VNRKCVDPCPNVCGQQAECRVRNHNPICTCLSGFTGDPFTRCYRQ-------PPPPPVVE 14277

Query:   299 NHCRDPC-PGTCGVQAICSVSNHIPICYCPAGFTGDAFRQCSPIPQREPEYRDPCSTTQC 357
                 DPC P  CG  + C   +  P C C   + G     C P    E      C + Q 
Sbjct: 14278 REPLDPCVPSPCGANSQCREIHGTPSCSCLPQYLGTP-PNCRP----ECSINAECPSHQA 14332

Query:   358 GLNAICT-VINGXXXXXXXXXXXHHIHKNQDMDQYISLGYMLCHMDILSSEYIQVYTVQP 416
              +N  C     G           +H      +  YI   + +C+ + +  E I+     P
Sbjct: 14333 CINQKCRDPCPGSCGLNTQCSVINHTPICSCLAGYIGDPFSVCNPEPIP-EKIR----DP 14387

Query:   417 VIQEDTCN---CVPNAECRDGVCVCLPDYYGDGYVSCRPECVQNSDCPRNKACIRNKCKN 473
             +  ED CN   C  N +C +GVC CLP+Y+GD Y  CRPECV ++DC R++AC+R+KC +
Sbjct: 14388 LPPEDPCNPSPCGSNTQCNNGVCSCLPEYHGDPYTGCRPECVLHTDCDRSRACVRHKCVD 14447

Query:   474 PCVPGTCGEGAICDVINHAVMCTCPPGTTGSPFIQCKPVQNEPVYTNPCQPSPCGPNSQC 533
             PC PGTCG  AIC+V+NH   C C  G  G+ FIQC PV    V  NPCQPSPCGPNSQC
Sbjct: 14448 PC-PGTCGTNAICEVLNHIPNCRCLEGMQGNAFIQCSPVPKLDVVQNPCQPSPCGPNSQC 14506

Query:   534 REVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVI 593
             R V++QA+CSC+ ++ GSPP CRPECT NS+CPL+ AC NQKC DPCPG CG+ A C V 
Sbjct: 14507 RVVNQQAICSCITSFIGSPPFCRPECTTNSECPLNLACRNQKCSDPCPGVCGRGAQCHVT 14566

Query:   594 NHNPSCTCKAGFTGDPRVFCSRIXXXXXXXXXXXYVNPCIPSPCGPYSQCRDINGSPSCS 653
             NH+P C C   +TG+P V C +I               C+PSPCGPYSQCR++N SPSC+
Sbjct: 14567 NHSPFCRCLERYTGNPFVSCQQIIEPPVPPPRQT----CLPSPCGPYSQCREVNESPSCT 14622

Query:   654 CLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPCPGSCGQGAQCRVINHSPVCYCPD 713
             CLP YIGAPPNCRPECV ++ECP ++ACI +KCRDPCPG CGQ A+CRV++H+P C CP+
Sbjct: 14623 CLPEYIGAPPNCRPECVTSSECPTNQACIQQKCRDPCPGLCGQSAECRVLSHTPSCVCPE 14682

Query:   714 GFIGDAFSSCYPKPIEPIQAPEQQADPCI---CAPNAVC--RDNV--CVCLPDYYGDGYT 766
             G  GD F+ C  K I+ +     Q DPC    C  NA C  R +   C CLPDY+G+ Y 
Sbjct: 14683 GMEGDPFTLCKEKRIQELD----QLDPCSPSPCGINARCTSRQDAGSCQCLPDYFGNPYE 14738

Query:   767 VCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQ 826
              CRPECV NSDC +NKAC + KC++PC PGTCG+ A+C+V+NH   CSC  G +G P+  
Sbjct: 14739 GCRPECVLNSDCPSNKACQQQKCQDPC-PGTCGQNALCNVLNHIPSCSCISGYSGDPYRS 14797

Query:   827 CKPVIQEPV--YTNPCQPSPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCP 884
             C P   EPV  Y NPCQPSPCGPNSQCREVN+QA+CSCLP Y G+PP CRPECT++++CP
Sbjct: 14798 CVP---EPVKEYVNPCQPSPCGPNSQCREVNEQAICSCLPEYVGAPPVCRPECTISSECP 14854

Query:   885 LDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPGFTGEPRIRCSPIP 935
              DKACVNQKCVDPCP +CG  A CRV+NHSPIC+CR G+TG+   RC P P
Sbjct: 14855 ADKACVNQKCVDPCPNTCGDQAICRVVNHSPICSCRAGYTGDAFFRCFPKP 14905


GO:0007475 "apposition of dorsal and ventral imaginal disc-derived wing surfaces" evidence=IMP
GO:0005578 "proteinaceous extracellular matrix" evidence=NAS
GO:0007424 "open tracheal system development" evidence=IMP
GO:0051539 "4 iron, 4 sulfur cluster binding" evidence=IEA
GO:0004867 "serine-type endopeptidase inhibitor activity" evidence=IEA
GO:0004519 "endonuclease activity" evidence=IEA
GO:0005509 "calcium ion binding" evidence=IEA
GO:0008362 "chitin-based embryonic cuticle biosynthetic process" evidence=IMP
GO:0040005 "chitin-based cuticle attachment to epithelium" evidence=IMP
GO:0031012 "extracellular matrix" evidence=ISM
GO:0005201 "extracellular matrix structural constituent" evidence=ISM
GO:0046331 "lateral inhibition" evidence=IMP
MGI|MGI:99460 Notch3 "notch 3" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-041001-184 si:dkey-30j22.1 "si:dkey-30j22.1" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-000329-5 notch3 "notch homolog 3" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
RGD|620761 Notch3 "notch 3" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|Q9R172 Notch3 "Neurogenic locus notch homolog protein 3" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|I3L9D5 NOTCH3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|E1BGE0 E1BGE0 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|Q04721 NOTCH2 "Neurogenic locus notch homolog protein 2" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|F1NXF9 Gga.18391 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

No hit with e-value below 0.005

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 1010
KOG4289|consensus 2531 99.81
KOG4289|consensus 2531 99.68
KOG1217|consensus487 99.63
KOG1217|consensus487 99.63
KOG1214|consensus1289 99.61
KOG1214|consensus1289 99.53
KOG0994|consensus 1758 99.53
KOG1219|consensus4289 99.31
KOG1219|consensus4289 99.24
KOG1225|consensus525 99.18
KOG0994|consensus1758 99.08
KOG1225|consensus525 99.03
KOG4260|consensus350 98.6
KOG1836|consensus 1705 98.56
KOG1836|consensus 1705 98.54
KOG4260|consensus350 98.47
KOG1226|consensus783 98.06
KOG1226|consensus783 97.89
PF0000832 EGF: EGF-like domain This is a sub-family of the P 97.74
PF0764542 EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 97.63
PF0764542 EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 97.62
PF0000832 EGF: EGF-like domain This is a sub-family of the P 97.6
smart0017939 EGF_CA Calcium-binding EGF-like domain. 97.51
smart0017939 EGF_CA Calcium-binding EGF-like domain. 97.31
PF06247197 Plasmod_Pvs28: Plasmodium ookinete surface protein 97.28
cd0005438 EGF_CA Calcium-binding EGF-like domain, present in 97.08
PF1294736 EGF_3: EGF domain; InterPro: IPR024731 This entry 96.89
PF1294736 EGF_3: EGF domain; InterPro: IPR024731 This entry 96.83
PF06247197 Plasmod_Pvs28: Plasmodium ookinete surface protein 96.83
cd0005438 EGF_CA Calcium-binding EGF-like domain, present in 96.82
cd0005336 EGF Epidermal growth factor domain, found in epide 96.34
cd0005336 EGF Epidermal growth factor domain, found in epide 96.28
smart0018135 EGF Epidermal growth factor-like domain. 96.21
smart0018135 EGF Epidermal growth factor-like domain. 96.11
KOG1218|consensus316 96.07
PF0797432 EGF_2: EGF-like domain; InterPro: IPR013111 A sequ 95.43
KOG1218|consensus316 95.16
PF0797432 EGF_2: EGF-like domain; InterPro: IPR013111 A sequ 94.8
PF1266224 cEGF: Complement Clr-like EGF-like 94.23
PF1266224 cEGF: Complement Clr-like EGF-like 94.14
PF1266113 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E 92.85
PF1266113 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E 92.79
smart0005163 DSL delta serrate ligand. 90.87
PF1467036 FXa_inhibition: Coagulation Factor Xa inhibitory s 90.1
PF1294637 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 88.78
PF1467036 FXa_inhibition: Coagulation Factor Xa inhibitory s 87.76
smart0005163 DSL delta serrate ligand. 83.43
PF1294637 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 82.41
PF0005349 Laminin_EGF: Laminin EGF-like (Domains III and V); 81.97
>KOG4289|consensus Back     alignment and domain information
Probab=99.81  E-value=3.5e-19  Score=209.59  Aligned_cols=112  Identities=31%  Similarity=0.774  Sum_probs=89.7

Q ss_pred             CCCCCCCCCCCCeee----------------------ecCCceeeeCCCCCccCCCCCcccCCCCCCCCCCCCCCCCCCC
Q psy5613          89 NPCVPGTCGEGAICD----------------------VVNHAVMCTCPPGTTGSPFIQCKPIQNEPVYTNPCQPSPCGPN  146 (1010)
Q Consensus        89 ~~C~~~~C~~~~~C~----------------------~~~g~~~C~C~~G~~g~~~~~C~~~~~~~~~~d~C~~~~C~~~  146 (1010)
                      +.|...||.|...|+                      +..++++|+|||||+|+.   |+      ..+|+|.+.||+++
T Consensus      1180 niClrEPCenymkCvsvlrFdssapf~~s~s~lfRpi~pvnglrCrCPpGFTgd~---Ce------TeiDlCYs~pC~nn 1250 (2531)
T KOG4289|consen 1180 NICLREPCENYMKCVSVLRFDSSAPFLASDSVLFRPIHPVNGLRCRCPPGFTGDY---CE------TEIDLCYSGPCGNN 1250 (2531)
T ss_pred             chhhcchhHHHHhhhhheeecccCccccccceeeeeccccCceeEeCCCCCCccc---cc------chhHhhhcCCCCCC
Confidence            345556777777772                      344789999999999998   98      67899999999999


Q ss_pred             CcceecCCCeeeecCCCCcCCCCCCCCCCccCCCCCCCCcccCCcccCCCCCCCCCCceEeec-CCCccccCCCC-CccC
Q psy5613         147 SQCREINHQAVCSCLPNYFGSPPGCRPECTVNSDCPLDRACQNQKCVDPCPGSCGYRARCQVY-NHNPVCSCPPG-YTGN  224 (1010)
Q Consensus       147 g~C~~~~g~~~C~C~~G~~g~~~~C~~~C~~~~~C~~~~~C~~~~C~~~C~~~C~~~~~C~~~-~g~~~C~C~~G-y~g~  224 (1010)
                      |+|....|+|+|+|.+||+|.      .||....   ...|.        |+.|.++++|++. .|.|.|.|+.| |++.
T Consensus      1251 g~C~srEggYtCeCrpg~tGe------hCEvs~~---agrCv--------pGvC~nggtC~~~~nggf~c~Cp~ge~e~p 1313 (2531)
T KOG4289|consen 1251 GRCRSREGGYTCECRPGFTGE------HCEVSAR---AGRCV--------PGVCKNGGTCVNLLNGGFCCHCPYGEFEDP 1313 (2531)
T ss_pred             CceEEecCceeEEecCCcccc------ceeeecc---cCccc--------cceecCCCEEeecCCCceeccCCCcccCCC
Confidence            999999999999999999999      8886532   12334        4578889999995 47899999998 4455


Q ss_pred             CC
Q psy5613         225 PF  226 (1010)
Q Consensus       225 ~c  226 (1010)
                      .|
T Consensus      1314 rC 1315 (2531)
T KOG4289|consen 1314 RC 1315 (2531)
T ss_pred             ce
Confidence            54



>KOG4289|consensus Back     alignment and domain information
>KOG1217|consensus Back     alignment and domain information
>KOG1217|consensus Back     alignment and domain information
>KOG1214|consensus Back     alignment and domain information
>KOG1214|consensus Back     alignment and domain information
>KOG0994|consensus Back     alignment and domain information
>KOG1219|consensus Back     alignment and domain information
>KOG1219|consensus Back     alignment and domain information
>KOG1225|consensus Back     alignment and domain information
>KOG0994|consensus Back     alignment and domain information
>KOG1225|consensus Back     alignment and domain information
>KOG4260|consensus Back     alignment and domain information
>KOG1836|consensus Back     alignment and domain information
>KOG1836|consensus Back     alignment and domain information
>KOG4260|consensus Back     alignment and domain information
>KOG1226|consensus Back     alignment and domain information
>KOG1226|consensus Back     alignment and domain information
>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins Back     alignment and domain information
>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins Back     alignment and domain information
>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>smart00179 EGF_CA Calcium-binding EGF-like domain Back     alignment and domain information
>smart00179 EGF_CA Calcium-binding EGF-like domain Back     alignment and domain information
>PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium Back     alignment and domain information
>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins Back     alignment and domain information
>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins Back     alignment and domain information
>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins Back     alignment and domain information
>PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium Back     alignment and domain information
>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins Back     alignment and domain information
>cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium Back     alignment and domain information
>cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium Back     alignment and domain information
>smart00181 EGF Epidermal growth factor-like domain Back     alignment and domain information
>smart00181 EGF Epidermal growth factor-like domain Back     alignment and domain information
>KOG1218|consensus Back     alignment and domain information
>PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>KOG1218|consensus Back     alignment and domain information
>PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>PF12662 cEGF: Complement Clr-like EGF-like Back     alignment and domain information
>PF12662 cEGF: Complement Clr-like EGF-like Back     alignment and domain information
>PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A Back     alignment and domain information
>PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A Back     alignment and domain information
>smart00051 DSL delta serrate ligand Back     alignment and domain information
>PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A Back     alignment and domain information
>PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein Back     alignment and domain information
>PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A Back     alignment and domain information
>smart00051 DSL delta serrate ligand Back     alignment and domain information
>PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein Back     alignment and domain information
>PF00053 Laminin_EGF: Laminin EGF-like (Domains III and V); InterPro: IPR002049 Laminins [] are the major noncollagenous components of basement membranes that mediate cell adhesion, growth migration, and differentiation Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1010
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 2e-07
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 2e-05
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 8e-05
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 2e-04
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-05
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 6e-05
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 9e-05
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 1e-04
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 2e-04
1yo8_A 634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 6e-05
1yo8_A 634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 1e-04
1yo8_A634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 9e-04
1uzk_A162 Fibrillin-1; glycoprotein, extra-cellular matrix, 5e-04
2dtg_E 897 Insulin receptor; IR ectodomain, X-RAY crystallogr 6e-04
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 8e-04
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 8e-04
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 Back     alignment and structure
 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 48/323 (14%), Positives = 66/323 (20%), Gaps = 45/323 (13%)

Query: 518 YTNPCQPSPCGPNSQCREVHKQAVCSCLPNYFGSPPNCRPECTVNSDCPL---DKACFNQ 574
           Y + C       N    +     +   +            +        L   D      
Sbjct: 360 YDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIVTVQV 419

Query: 575 KCVDPCPGTCGQNANCRVINHNP----SCTCKAGFTGDPRVFCSRIPPPPPQESPPEYVN 630
                C                      C C  G+ G     C                 
Sbjct: 420 LPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGK---NCE--------------CQ 462

Query: 631 PCIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACINEKCRDPC 690
               S       CR  N S  CS L + +     C        +  Y + C  +      
Sbjct: 463 TQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSD-VPGKLIYGQYCECDTINCER 521

Query: 691 PGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCR 750
                 G   R +     C C  GF G A         E             C+    CR
Sbjct: 522 YNGQVCGGPGRGLCFCGKCRCHPGFEGSACQ------CERTTEGCLNPRRVECSGRGRCR 575

Query: 751 DNVCVCLPDYYGDG---YTVCRPECVRNSDCANNKACIRN--------KCKNPCVPGTCG 799
            NVC C   Y          C   C +   CA      +          C    +     
Sbjct: 576 CNVCECHSGYQLPLCQECPGCPSPCGKYISCAECLKFEKGPFGKNCSAACPGLQLSNNPV 635

Query: 800 EGAICDVINHSVVCSCPPGTTGS 822
           +G  C   +      C    T  
Sbjct: 636 KGRTCKERD---SEGCWVAYTLE 655


>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 Back     alignment and structure
>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 Back     alignment and structure
>2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E Length = 897 Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1010
4fbr_A267 Lectin, myxobacterial hemagglutinin; beta-barrel, 99.85
4fbr_A267 Lectin, myxobacterial hemagglutinin; beta-barrel, 99.84
2vj3_A135 Neurogenic locus notch homolog protein 1; transcri 99.79
1z1y_A186 Ookinete surface protein PVS25; four EGF-like doma 99.79
1z1y_A186 Ookinete surface protein PVS25; four EGF-like doma 99.78
2vj3_A135 Neurogenic locus notch homolog protein 1; transcri 99.77
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 99.72
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 99.71
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 99.69
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 99.69
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 99.68
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 99.61
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 99.59
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 99.58
1yo8_A634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 99.58
1yo8_A634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 99.58
1uzk_A162 Fibrillin-1; glycoprotein, extra-cellular matrix, 99.57
2bou_A143 EGF-like module containing mucin-like hormone rece 99.57
1uzk_A162 Fibrillin-1; glycoprotein, extra-cellular matrix, 99.53
2bou_A143 EGF-like module containing mucin-like hormone rece 99.51
1dx5_I118 Thrombomodulin; serine proteinase, EGF-like domain 99.45
1dx5_I118 Thrombomodulin; serine proteinase, EGF-like domain 99.42
2w86_A147 Fibrillin-1, fibrillin1; phosphoprotein, EGF-like 99.39
2w86_A147 Fibrillin-1, fibrillin1; phosphoprotein, EGF-like 99.38
2gy5_A423 Angiopoietin-1 receptor; ligand-binding domain, tr 99.34
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 99.34
2gy5_A423 Angiopoietin-1 receptor; ligand-binding domain, tr 99.3
1tpg_A91 T-plasminogen activator F1-G; plasminogen activati 99.28
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 99.28
1tpg_A91 T-plasminogen activator F1-G; plasminogen activati 99.27
4aqs_A525 Laminin subunit beta-1; cell adhesion; HET: NAG BM 99.15
1aut_L114 Activated protein C; serine proteinase, plasma cal 99.1
1emn_A82 Fibrillin; extracellular matrix, calcium-binding, 99.1
1emn_A82 Fibrillin; extracellular matrix, calcium-binding, 99.09
1lmj_A86 Fibrillin 1; EGF, calcium, microfibril, neonatal, 99.04
4aqs_A525 Laminin subunit beta-1; cell adhesion; HET: NAG BM 99.03
1lmj_A86 Fibrillin 1; EGF, calcium, microfibril, neonatal, 99.02
1x7a_L146 Coagulation factor IX, light chain; inhibition, bl 99.01
1aut_L114 Activated protein C; serine proteinase, plasma cal 99.0
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 98.96
1z6c_A87 Vitamin K-dependent protein S; EGF module, blood c 98.96
2vh0_B134 Activated factor XA light chain; serine protease, 98.93
1x7a_L146 Coagulation factor IX, light chain; inhibition, bl 98.93
2c4f_L142 Coagulation factor VII precursor; blood coagulatio 98.92
2c4f_L142 Coagulation factor VII precursor; blood coagulatio 98.89
1n7d_A699 LDL receptor, low-density lipoprotein receptor; fa 98.88
1z6c_A87 Vitamin K-dependent protein S; EGF module, blood c 98.86
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 98.83
2vh0_B134 Activated factor XA light chain; serine protease, 98.78
2w2n_E107 LDL receptor, low-density lipoprotein receptor; hy 98.77
2w2n_E107 LDL receptor, low-density lipoprotein receptor; hy 98.77
1klo_A162 Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: 98.71
3h5c_B317 Vitamin K-dependent protein Z; protein Z-protein Z 98.7
3h5c_B317 Vitamin K-dependent protein Z; protein Z-protein Z 98.69
1n7d_A699 LDL receptor, low-density lipoprotein receptor; fa 98.67
2p28_B217 Integrin beta-2; hybrid domain, PSI domain, I-EGF 98.61
3m0c_C791 LDL receptor, low-density lipoprotein receptor; pr 98.57
1klo_A162 Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: 98.54
3m0c_C791 LDL receptor, low-density lipoprotein receptor; pr 98.46
2p28_B217 Integrin beta-2; hybrid domain, PSI domain, I-EGF 98.45
1edm_B39 Factor IX; epidermal growth factor, EGF, calcium- 98.36
3u7u_G55 Neuregulin 1; signaling protein, transferase-trans 98.34
3u7u_G55 Neuregulin 1; signaling protein, transferase-trans 98.24
1edm_B39 Factor IX; epidermal growth factor, EGF, calcium- 98.21
3p5b_L400 Low density lipoprotein receptor variant; B-propel 98.2
3p5b_L400 Low density lipoprotein receptor variant; B-propel 98.09
3v65_B386 Low-density lipoprotein receptor-related protein; 98.02
1egf_A53 Epidermal growth factor; NMR {Mus musculus} SCOP: 97.98
3v65_B 386 Low-density lipoprotein receptor-related protein; 97.92
1a3p_A45 Epidermal growth factor; disulfide connectivities, 97.92
2k2s_B61 Micronemal protein 6; microneme protein complex, c 97.81
1a3p_A45 Epidermal growth factor; disulfide connectivities, 97.78
2k2s_B61 Micronemal protein 6; microneme protein complex, c 97.75
1hae_A63 Heregulin-alpha; growth factor; NMR {Homo sapiens} 97.74
1egf_A53 Epidermal growth factor; NMR {Mus musculus} SCOP: 97.74
1k36_A46 Epiregulin; EGF-like fold, hormone/growth factor c 97.68
1hae_A63 Heregulin-alpha; growth factor; NMR {Homo sapiens} 97.68
2wg3_C463 Hedgehog-interacting protein; lipoprotein, develop 97.55
1k36_A46 Epiregulin; EGF-like fold, hormone/growth factor c 97.54
3zyj_B426 Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA 97.51
3zyj_B426 Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA 97.45
2wg3_C463 Hedgehog-interacting protein; lipoprotein, develop 97.44
3ca7_A52 Protein spitz; argos, EGF, developmental protein, 97.25
3ca7_A52 Protein spitz; argos, EGF, developmental protein, 97.17
1nql_B53 Epidermal growth factor; cell surface receptor, ty 96.87
2kl7_A71 Fibulin-4; secreted, calcium, disease mutation, di 96.81
1apq_A53 Complement protease C1R; EGF, calcium binding, ser 96.79
1nql_B53 Epidermal growth factor; cell surface receptor, ty 96.78
1apq_A53 Complement protease C1R; EGF, calcium binding, ser 96.64
1gl4_A285 Nidogen-1, entactin; immunoglobulin-like domain, e 96.57
2jkh_L55 Factor X light chain; plasma, calcium, zymogen, se 96.44
2kl7_A71 Fibulin-4; secreted, calcium, disease mutation, di 96.42
2fd6_A122 Urokinase-type plasminogen activator; UPAR, ATF, A 96.33
1ob1_C99 Major merozoite surface protein; immune system, im 96.17
1kli_L69 Factor VIIA; extrinsic coagulation pathway, serine 96.07
1g1s_A162 P-selectin; selectin, lectin, EGF, sulphated, SLEX 96.01
1ob1_C99 Major merozoite surface protein; immune system, im 95.93
2fd6_A122 Urokinase-type plasminogen activator; UPAR, ATF, A 95.87
1g1s_A162 P-selectin; selectin, lectin, EGF, sulphated, SLEX 95.74
3ltf_D58 Protein spitz; receptor-ligand complex ectodomain 95.54
1gl4_A285 Nidogen-1, entactin; immunoglobulin-like domain, e 95.37
1n1i_A105 Merozoite surface protein-1; MSP1, malaria, surfac 95.25
2jkh_L55 Factor X light chain; plasma, calcium, zymogen, se 95.2
3ltf_D58 Protein spitz; receptor-ligand complex ectodomain 95.19
1kli_L69 Factor VIIA; extrinsic coagulation pathway, serine 94.76
1n1i_A105 Merozoite surface protein-1; MSP1, malaria, surfac 94.62
1kig_L51 Factor XA; glycoprotein, serine protease, plasma, 94.54
1q4g_A553 Prostaglandin G/H synthase 1; cyclooxygenase, non- 94.48
1q4g_A553 Prostaglandin G/H synthase 1; cyclooxygenase, non- 94.16
3nt1_A587 Prostaglandin-endoperoxide synthase 2; prostagland 94.11
3nt1_A587 Prostaglandin-endoperoxide synthase 2; prostagland 93.91
2bz6_L53 Blood coagulation factor VIIA; serine protease, en 93.04
1kig_L51 Factor XA; glycoprotein, serine protease, plasma, 92.43
3cfw_A164 L-selectin; EGF, cell adhesion, EGF-like domain, g 92.35
1g1t_A157 E-selectin; EGF, adhesion molecule, SLEX, immune s 92.1
3cfw_A164 L-selectin; EGF, cell adhesion, EGF-like domain, g 91.77
1szb_A170 Mannose binding lectin-associated serine protease- 91.6
1xdt_R79 Hbegf, heparin-binding epidermal growth factor; co 91.14
3e50_C50 Protransforming growth factor alpha; IDE, TGF-alph 91.01
1xdt_R79 Hbegf, heparin-binding epidermal growth factor; co 90.83
2i9a_A145 Urokinase-type plasminogen activator; growth facto 90.78
2i9a_A145 Urokinase-type plasminogen activator; growth facto 90.53
1iox_A50 Betacellulin; EGF-like fold, hormone/growth factor 90.5
2rnl_A50 Amphiregulin; AR, colorectum cell-derived growth f 90.45
1oig_A26 Dumpy, CG33196-PB; structural protein; NMR {Drosop 90.43
3e50_C50 Protransforming growth factor alpha; IDE, TGF-alph 89.81
2bz6_L53 Blood coagulation factor VIIA; serine protease, en 89.23
1iox_A50 Betacellulin; EGF-like fold, hormone/growth factor 89.23
1g1t_A157 E-selectin; EGF, adhesion molecule, SLEX, immune s 89.03
2rnl_A50 Amphiregulin; AR, colorectum cell-derived growth f 88.89
1szb_A170 Mannose binding lectin-associated serine protease- 88.84
2y38_A403 Laminin subunit alpha-5; structural protein, cell 87.98
2ygo_A188 WIF-1, WNT inhibitory factor 1; signaling protein, 87.72
2ygo_A188 WIF-1, WNT inhibitory factor 1; signaling protein, 87.71
4aqt_A375 Laminin subunit gamma-1; cell adhesion; HET: NAG B 87.27
2wph_E59 Coagulation factor IXA light chain; serine proteas 86.01
4aqt_A375 Laminin subunit gamma-1; cell adhesion; HET: NAG B 85.99
3asi_A410 Neurexin-1-alpha; beta-sandwich, cell adhesion, sy 85.23
2y38_A403 Laminin subunit alpha-5; structural protein, cell 84.21
3asi_A410 Neurexin-1-alpha; beta-sandwich, cell adhesion, sy 83.51
2wph_E59 Coagulation factor IXA light chain; serine proteas 81.8
2p26_A280 Integrin beta-2; hybrid domain, PSI domain, I-EGF 81.32
2p26_A280 Integrin beta-2; hybrid domain, PSI domain, I-EGF 81.1
>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* Back     alignment and structure
Probab=99.85  E-value=3.5e-25  Score=232.03  Aligned_cols=252  Identities=11%  Similarity=-0.023  Sum_probs=177.8

Q ss_pred             cccccCCCeeeecCCC---ccCCCCCCcCCCccCCCCCCCccccCCcccCCCCCCCCCCceeeccCCCceeecCCCCccC
Q psy5613         532 QCREVHKQAVCSCLPN---YFGSPPNCRPECTVNSDCPLDKACFNQKCVDPCPGTCGQNANCRVINHNPSCTCKAGFTGD  608 (1010)
Q Consensus       532 ~C~~~~g~~~C~C~~G---~~G~~~~C~~~C~~~~~C~~~~~C~~~~C~~~C~~~C~~~~~C~~~~~~~~C~C~~Gy~G~  608 (1010)
                      ++.+..|+|++.+.+|   |+|.  +++.    +.              ..+...|.++++|++..++|+|.|++||+|.
T Consensus         5 ~~~n~~Gg~s~~~~pgg~~~~g~--~~~~----n~--------------~~~~~~c~ngG~C~~g~~~y~C~Cp~Gf~G~   64 (267)
T 4fbr_A            5 LVQNQWGGSQATWNPGGLWLIGA--RDKQ----NV--------------VALDIKSDDGGKTLKGTMTYNGEGPIGFRGT   64 (267)
T ss_dssp             EEEEECSSTTSCCEEEEEEECCC--CSSC----CE--------------EEEEEECSSTTSEEEEEEEETTSCCEEEEEE
T ss_pred             eEeecCCcccCCcCCCCceeecc--cccc----cc--------------ccCCCCcCCCCeecCCCCCeEEeCCCCcccc
Confidence            3557788999999988   4454  3321    11              1112367889999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCCCCCCC------CCCCCCCCCCccccCCCCceeeCCCCcccCCCCCccCCcCCCCCCCCcccc
Q psy5613         609 PRVFCSRIPPPPPQESPPEYVNP------CIPSPCGPYSQCRDINGSPSCSCLPNYIGAPPNCRPECVQNTECPYDKACI  682 (1010)
Q Consensus       609 ~~~~C~~~~~~~~~~~~~~~id~------C~~~~C~~~g~C~~~~g~y~C~C~~G~~g~~~~C~~~C~~~~~C~~~~~C~  682 (1010)
                      .   |+            ++|++      |.+.||+++++|              |.|.  +|+    ..++|.      
T Consensus        65 ~---Ce------------~ni~ec~~~~~c~s~pC~nggtc--------------~~G~--~c~----~~~eC~------  103 (267)
T 4fbr_A           65 L---SS------------ANNYTVENQWGGTSAPWQPGGVW--------------VLGA--RDK----QNIVAV------  103 (267)
T ss_dssp             E---CS------------TTEEEEEEESSSTTSCEEEEEEE--------------ECCC--CSS----CCEEEE------
T ss_pred             c---cc------------ccccccccccCcCCCcccCCCee--------------eccC--ccc----cccccC------
Confidence            6   87            68888      666677776654              3455  443    333443      


Q ss_pred             CCccCCCCCCCCCCCCeeeeeCCcceeeCCCCCccCCCccCCCCCCCCCCCCCCCCCCCCCCCCCcccCceeecCCCccC
Q psy5613         683 NEKCRDPCPGSCGQGAQCRVINHSPVCYCPDGFIGDAFSSCYPKPIEPIQAPEQQADPCICAPNAVCRDNVCVCLPDYYG  762 (1010)
Q Consensus       683 ~~~C~~~C~~~C~~~~~C~~~~g~~~C~C~~G~~G~~C~~C~~~~~~~~~~~~c~~~~c~C~~~g~C~~~~C~C~~G~~G  762 (1010)
                              +.+|.++++|++...+|+|+|++||+|..|+         +++++|...+  +.+.+.|.+    +..+|.|
T Consensus       104 --------s~pC~ngG~C~~~~~sy~C~C~~Gf~G~~Ce---------~~~d~C~n~~--~c~s~pC~n----gg~c~~G  160 (267)
T 4fbr_A          104 --------SIKSNDGGKTLTGTTTYNGEGPIGFKSEVTD---------GDTYSVENQW--GGSAAPWHS----GGVWVLG  160 (267)
T ss_dssp             --------EEECSSTTSEEEEEEEETTSCCEEEEEEECC---------CCEEEEEEEC--SSTTSCCEE----EEEEECC
T ss_pred             --------CCCCCCCCEEecCCccEEeeCCCCccccCCC---------CCcccccccC--CcCCccccC----Ccceecc
Confidence                    3478999999999999999999999999998         4666644333  222222322    1112456


Q ss_pred             CCCcccCCCCCCCCCCCCCcccccCCccCCCCCCCCCCCCeeeecCCeeeeeCCCCCccCCCccccCCccCCCCCCCCCC
Q psy5613         763 DGYTVCRPECVRNSDCANNKACIRNKCKNPCVPGTCGEGAICDVINHSVVCSCPPGTTGSPFIQCKPVIQEPVYTNPCQP  842 (1010)
Q Consensus       763 ~~c~~~~~~C~~~~~C~~~~~C~~~~C~~~C~~~~C~~~~~C~~~~g~y~C~C~~G~~G~~~~~C~~~~~~~~~~~~C~~  842 (1010)
                      ..++..++                      |.+.+|.++++|++..++|+|.|++||+|.   +|+..+      ++|..
T Consensus       161 ~~c~~~i~----------------------c~~~~c~ngg~C~dg~~~y~C~Cp~Gf~G~---~c~~~i------~ec~~  209 (267)
T 4fbr_A          161 TRGKQNVI----------------------NVDAKSNDGGKTLSGTMTYNGEGPIGFRGT---LTSPDT------YTVEN  209 (267)
T ss_dssp             SSTTSCEE----------------------EEEEECSSTTSEEEEEEEETTSCCEEEEEE---EEETTE------EEEEE
T ss_pred             cccccccc----------------------cCCCCCCCCCEeeCCCCCeEEeCCCCcccc---cccccc------ceecc
Confidence            66654321                      115678999999999999999999999999   598754      66544


Q ss_pred             CCCCCCCceeecCCceeeecCCCCcCCCCCCCCCCccCCCCCCcccccCCcccCCCCCCCCCCCeeeecCCCceeeCCCC
Q psy5613         843 SPCGPNSQCREVNKQAVCSCLPNYFGSPPNCRPECTVNTDCPLDKACVNQKCVDPCPGSCGQNANCRVINHSPICTCRPG  922 (1010)
Q Consensus       843 ~~C~~~~~C~~~~g~~~C~C~~G~~g~~~~C~~~C~~~~~C~~~~~C~~~~C~~~C~~~C~~~~~C~~~~g~~~C~C~~G  922 (1010)
                      .++...+.|.+. |.|.+.|..|+...      .|+                     .+|.++|+|++.+.+|+|.||+|
T Consensus       210 ~~~c~~~~c~~g-G~~~~~C~~g~n~~------~c~---------------------~~c~ngGtC~dg~~sy~CeCp~G  261 (267)
T 4fbr_A          210 QWGGSTAPWNPG-GFWMIGARNGQNVV------ALN---------------------VASSDGGKTLAGTMIYNGEGPIG  261 (267)
T ss_dssp             ECSCTTSCCEEE-EEEECCCCTTCCEE------EEE---------------------EECSSTTSEEEEEEEETTSCCEE
T ss_pred             CCCccCCcccCC-CeEEEecCCCCccc------cCC---------------------cCCCCCCEeeCCCcceeecCCCC
Confidence            433344555554 45667788888766      222                     25778999999999999999999


Q ss_pred             CcCC
Q psy5613         923 FTGE  926 (1010)
Q Consensus       923 ~~G~  926 (1010)
                      |+|.
T Consensus       262 F~G~  265 (267)
T 4fbr_A          262 FRAR  265 (267)
T ss_dssp             EEEE
T ss_pred             cccc
Confidence            9985



>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* Back     alignment and structure
>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Back     alignment and structure
>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Back     alignment and structure
>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Back     alignment and structure
>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Back     alignment and structure
>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Back     alignment and structure
>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Back     alignment and structure
>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Back     alignment and structure
>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Back     alignment and structure
>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Back     alignment and structure
>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Back     alignment and structure
>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Back     alignment and structure
>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Back     alignment and structure
>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Back     alignment and structure
>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Back     alignment and structure
>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Back     alignment and structure
>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Back     alignment and structure
>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Back     alignment and structure
>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Back     alignment and structure
>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Back     alignment and structure
>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Back     alignment and structure
>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Back     alignment and structure
>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Back     alignment and structure
>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Back     alignment and structure
>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Back     alignment and structure
>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Back     alignment and structure
>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Back     alignment and structure
>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Back     alignment and structure
>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Back     alignment and structure
>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A Back     alignment and structure
>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Back     alignment and structure
>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Back     alignment and structure
>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Back     alignment and structure
>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Back     alignment and structure
>1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A Back     alignment and structure
>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Back     alignment and structure
>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Back     alignment and structure
>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A Back     alignment and structure
>2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A Back     alignment and structure
>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} Back     alignment and structure
>1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A Back     alignment and structure
>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} Back     alignment and structure
>2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A Back     alignment and structure
>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Back     alignment and structure
>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} Back     alignment and structure
>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} Back     alignment and structure
>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Back     alignment and structure
>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Back     alignment and structure
>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Back     alignment and structure
>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Back     alignment and structure
>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A Back     alignment and structure
>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Back     alignment and structure
>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 Back     alignment and structure
>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A Back     alignment and structure
>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 Back     alignment and structure
>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A Back     alignment and structure
>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A Back     alignment and structure
>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A Back     alignment and structure
>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A Back     alignment and structure
>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A Back     alignment and structure
>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Back     alignment and structure
>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A Back     alignment and structure
>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Back     alignment and structure
>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D Back     alignment and structure
>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D Back     alignment and structure
>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* Back     alignment and structure
>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} Back     alignment and structure
>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* Back     alignment and structure
>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A Back     alignment and structure
>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... Back     alignment and structure
>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} Back     alignment and structure
>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A Back     alignment and structure
>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Back     alignment and structure
>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* Back     alignment and structure
>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Back     alignment and structure
>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Back     alignment and structure
>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A Back     alignment and structure
>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Back     alignment and structure
>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} Back     alignment and structure
>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A Back     alignment and structure
>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 Back     alignment and structure
>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... Back     alignment and structure
>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} Back     alignment and structure
>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* Back     alignment and structure
>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 Back     alignment and structure
>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 Back     alignment and structure
>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... Back     alignment and structure
>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... Back     alignment and structure
>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... Back     alignment and structure
>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... Back     alignment and structure
>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* Back     alignment and structure
>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 Back     alignment and structure
>3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} Back     alignment and structure
>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Back     alignment and structure
>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 Back     alignment and structure
>1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A Back     alignment and structure
>1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* Back     alignment and structure
>2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* Back     alignment and structure
>1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A Back     alignment and structure
>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} Back     alignment and structure
>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A Back     alignment and structure
>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* Back     alignment and structure
>1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A Back     alignment and structure
>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Back     alignment and structure
>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} Back     alignment and structure
>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 Back     alignment and structure
>2y38_A Laminin subunit alpha-5; structural protein, cell adhesion, basement membrane; HET: NAG; 2.90A {Mus musculus} Back     alignment and structure
>2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* Back     alignment and structure
>2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* Back     alignment and structure
>4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} Back     alignment and structure
>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* Back     alignment and structure
>4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} Back     alignment and structure
>3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} Back     alignment and structure
>2y38_A Laminin subunit alpha-5; structural protein, cell adhesion, basement membrane; HET: NAG; 2.90A {Mus musculus} Back     alignment and structure
>3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} Back     alignment and structure
>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* Back     alignment and structure
>2p26_A Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 1.75A {Homo sapiens} PDB: 1yuk_B* 1yuk_A* 2p28_A* Back     alignment and structure
>2p26_A Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 1.75A {Homo sapiens} PDB: 1yuk_B* 1yuk_A* 2p28_A* Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

No hit with e-value below 0.005

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1010
d1edmb_39 Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 98.66
d2vj3a142 Neurogenic locus notch homolog protein 1, Notch1 { 98.63
d2c4fl137 Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} 98.6
d2vj3a239 Neurogenic locus notch homolog protein 1, Notch1 { 98.59
d1edmb_39 Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 98.56
d2vj3a239 Neurogenic locus notch homolog protein 1, Notch1 { 98.53
d2vj3a142 Neurogenic locus notch homolog protein 1, Notch1 { 98.46
d2c4fl137 Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} 98.45
d2vj3a335 Neurogenic locus notch homolog protein 1, Notch1 { 98.42
d1xkba139 Factor X, N-terminal module {Human (Homo sapiens) 98.41
d2vj3a335 Neurogenic locus notch homolog protein 1, Notch1 { 98.41
d1xkba139 Factor X, N-terminal module {Human (Homo sapiens) 98.36
d1emoa143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 98.28
d1g1ta239 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.25
d1autl148 Activated protein c (autoprothrombin IIa) {Human ( 98.13
d1g1ta239 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.12
d1tpga141 Plasminogen activator (tissue-type), t-PA {Human ( 98.11
d1g1sa240 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.11
d1g1sa240 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.1
d1emoa143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 98.08
d1tpga141 Plasminogen activator (tissue-type), t-PA {Human ( 98.05
d1q4ga242 Prostaglandin H2 synthase-1, EGF-like module {Shee 98.01
d1q4ga242 Prostaglandin H2 synthase-1, EGF-like module {Shee 97.94
d1autl148 Activated protein c (autoprothrombin IIa) {Human ( 97.93
d1cvua241 Prostaglandin H2 synthase-1, EGF-like module {Mous 97.88
d1cvua241 Prostaglandin H2 synthase-1, EGF-like module {Mous 97.87
d1lmja144 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.81
d1lmja144 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.77
d1uzka143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.67
d1uzka143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.64
d1lmja242 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.62
d1haea_63 Heregulin-alpha, EGF-like domain {Human (Homo sapi 97.53
d1lmja242 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.49
d1gl4a240 EGF-like domain of nidogen-1 {Mouse (Mus musculus) 97.49
d1haea_63 Heregulin-alpha, EGF-like domain {Human (Homo sapi 97.41
d1dx5i340 Thrombomodulin, different EGF-like domains {Human 97.4
d1uzka243 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.35
d1uzka243 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.34
d1apqa_53 Complement protease C1R {Human (Homo sapiens) [Tax 97.32
d1dx5i340 Thrombomodulin, different EGF-like domains {Human 97.29
d1gl4a240 EGF-like domain of nidogen-1 {Mouse (Mus musculus) 97.28
d1apqa_53 Complement protease C1R {Human (Homo sapiens) [Tax 97.23
d3egfa_53 Epidermal growth factor, EGF {Mouse (Mus musculus) 97.17
d1i0ua241 Low density lipoprotein (LDL) receptor, different 97.14
d1nt0a345 Mannose-binding protein associated serine protease 97.08
d3egfa_53 Epidermal growth factor, EGF {Mouse (Mus musculus) 97.01
d1szba245 Mannose-binding protein associated serine protease 96.99
d1i0ua241 Low density lipoprotein (LDL) receptor, different 96.98
d1nqlb_48 Epidermal growth factor, EGF {Human (Homo sapiens) 96.95
d1nqlb_48 Epidermal growth factor, EGF {Human (Homo sapiens) 96.94
d1nt0a345 Mannose-binding protein associated serine protease 96.58
d1szba245 Mannose-binding protein associated serine protease 96.58
d3bpse140 Low density lipoprotein (LDL) receptor, different 96.48
d1emoa239 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.44
d1emoa239 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.26
d1nzia242 Complement C1S component {Human (Homo sapiens) [Ta 96.14
d1nzia242 Complement C1S component {Human (Homo sapiens) [Ta 95.8
d3bpse140 Low density lipoprotein (LDL) receptor, different 95.61
d2i9aa140 Plasminogen activator (urokinase-type) {Human (Hom 95.57
d2i9aa140 Plasminogen activator (urokinase-type) {Human (Hom 95.01
d1k36a_46 Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI 94.6
d1k36a_46 Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI 94.24
d1l3ya_41 Integrin beta EGF-like domains {Human (Homo sapien 93.64
d1ioxa_50 Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] 93.53
d1ioxa_50 Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] 92.79
d1moxc_49 Transforming growth factor alpha {Human (Homo sapi 92.71
d1jv2b431 Integrin beta EGF-like domains {Human (Homo sapien 92.52
d1l3ya_41 Integrin beta EGF-like domains {Human (Homo sapien 92.23
d1moxc_49 Transforming growth factor alpha {Human (Homo sapi 91.66
d1jv2b431 Integrin beta EGF-like domains {Human (Homo sapien 91.21
d1autl250 Activated protein c (autoprothrombin IIa) {Human ( 90.64
d1kigl_51 Factor X, N-terminal module {Cow (Bos taurus) [Tax 90.17
d2p3ua151 Factor X, N-terminal module {Human (Homo sapiens) 88.65
d1xdtr_41 Heparin-binding epidermal growth factor, HBEGF {Hu 88.12
d1jv2b543 Integrin beta EGF-like domains {Human (Homo sapien 87.36
d2p3ua151 Factor X, N-terminal module {Human (Homo sapiens) 86.14
d1jv2b543 Integrin beta EGF-like domains {Human (Homo sapien 85.98
d1kigl_51 Factor X, N-terminal module {Cow (Bos taurus) [Tax 85.5
d1xdtr_41 Heparin-binding epidermal growth factor, HBEGF {Hu 85.48
d1autl250 Activated protein c (autoprothrombin IIa) {Human ( 84.9
d1oiga_26 Dumpy {Fruit fly (Drosophila melanogaster) [TaxId: 82.97
>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66  E-value=8.6e-09  Score=72.79  Aligned_cols=38  Identities=24%  Similarity=0.507  Sum_probs=36.0

Q ss_pred             CCCCCCCCCCCCCCCeecccCCceeeeeCCCCccCCCC
Q psy5613         241 TPTDPCFPSPCGSNARCRVQNEHALCECLPDYYGNPYE  278 (1010)
Q Consensus       241 ~~~d~C~~~~C~~~~~C~~~~g~~~C~C~~Gf~G~~c~  278 (1010)
                      +|+|+|+++||.++|+|++..++|+|.|++||+|+.|+
T Consensus         1 id~d~C~~~PC~ngg~C~~~~~~y~C~C~~g~~G~~Ce   38 (39)
T d1edmb_           1 VDGDQCESNPCLNGGSCKDDINSYECWCPFGFEGKNCE   38 (39)
T ss_dssp             CCCCTTTTCCCCTTCEEEEETTEEEEECCTTCCSTTSC
T ss_pred             CccccCCCCCCCCCcEEEcCCCCEEEECCCCCCCCCCC
Confidence            37899999999999999999999999999999999876



>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Back     information, alignment and structure
>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Back     information, alignment and structure
>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} Back     information, alignment and structure
>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} Back     information, alignment and structure
>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1l3ya_ g.3.11.6 (A:) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jv2b4 g.3.11.6 (B:532-562) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1l3ya_ g.3.11.6 (A:) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jv2b4 g.3.11.6 (B:532-562) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jv2b5 g.3.11.6 (B:563-605) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jv2b5 g.3.11.6 (B:563-605) Integrin beta EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1oiga_ g.3.18.1 (A:) Dumpy {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure